Cognition Therapeutics' Series B Round

Cognition Therapeutics raised a round of funding on January 12, 2012.

Cognition Therapeutics is focused on the discovery and development of small molecule therapeutics targeting toxic proteins that cause the cognitive decline associated with Alzheimer's disease and othe…

Articles about Cognition Therapeutics' Series B Round: